Navigation Links
Pharmaxis Investor Conference Call
Date:1/26/2009

SYDNEY, Australia, Jan. 27 /PRNewswire-Asia/ -- Pharmaxis Ltd (AXS: PXS, Nasdaq: PXSL) will release its December 2008 Quarterly Report to Shareholders on the afternoon of Wednesday, 28th January 2009. Dr. Alan Robertson will host an investor teleconference the following morning to review the quarter and answer investor questions.

The teleconference will be on Thursday, 29th January at 8:30am (Sydney), (Wednesday, 28th January at 4:30pm U.S. East Coast, 1:30pm U.S. West Coast).

    Telephone access (toll free) details are below:
    -- Australia: 1800 131 617
    -- USA/Canada:  866 746 2596
    -- UK: 0800 376 8339
    -- NZ: 0800 446 958
    -- Switzerland: 0800 001 230
    -- Online (global access):
      http://services.choruscall.com/links/pharmaxis090129.html

A recording of the conference will be available on the Pharmaxis website home page approximately 3 hours after the call.


    CONTACT: Pharmaxis Investor Relations
    T: +61 2 9454 7200, F +61 2 9451 3622
    E: Investor.Relations@Pharmaxis.com.au
       Website: www.pharmaxis.com.au


'/>"/>
SOURCE Pharmaxis Ltd
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Pharmaxis Aridol Approved for Sale in Switzerland
2. Pharmaxis Investor Conference Call
3. Pharmaxis Research Programs Highlighted at European Respiratory Society Congress
4. New Pharmaxis Board Appointment
5. Pharmaxis Aridol Authorised for Sale in Germany
6. Pharmaxis First Steps into China
7. Pharmaxis to Apply to Market Bronchitol in Australia
8. Pharmaxis Investor Conference Call
9. Pharmaxis Aridol Gains First Asian Approval
10. Pharmaxis Appoints Portuguese Distributor for Aridol
11. Pharmaxis Closes Share Purchase Plan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... 2016 Houston Methodist Willowbrook Hospital has ... Association to serve as their official health care ... Willowbrook will provide sponsorship support, athletic training services, ... coaches, volunteers, athletes and families. "We ... Association and to bring Houston Methodist quality services ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
(Date:6/23/2016)... 2016   EpiBiome , a precision microbiome engineering ... debt financing from Silicon Valley Bank (SVB). The financing ... advance its drug development efforts, as well as purchase ... "SVB has been an incredible strategic partner to us ... bank would provide," said Dr. Aeron Tynes Hammack ...
Breaking Biology Technology:
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour ... from the Q1 wave of its quarterly wearables survey. ... receptivity to a program where they would receive discounts ... company. "We were surprised to see that ... LaColla , CEO of Troubadour Research, "primarily because there ...
(Date:4/28/2016)... and BANGALORE, India , April 28, ... Systems, a product subsidiary of Infosys (NYSE: INFY ... announced a global partnership that will provide end ... use mobile banking and payment services.      (Logo: ... key innovation area for financial services, but it also plays ...
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
Breaking Biology News(10 mins):